{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:52:10Z","timestamp":1791388330424,"version":"4.3.3"},"reference-count":8,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:p>This cohort study evaluates early treatment trends of oral semaglutide among adults eligible for obesity management medications following its approval for obesity.<\/jats:p>","DOI":"10.1001\/jamanetworkopen.2026.37779","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:00:27Z","timestamp":1791385227000},"page":"e2637779","source":"Crossref","is-referenced-by-count":0,"title":["Early Adoption and Diffusion of Oral Semaglutide in US Adults With Obesity"],"prefix":"10.1001","volume":"9","author":[{"given":"Yuqing","family":"Lei","sequence":"first","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia"},{"name":"The Center for Health AI and Synthesis of Evidence, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilin","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia"},{"name":"The Center for Health AI and Synthesis of Evidence, University of Pennsylvania, Philadelphia"},{"name":"Center for Preventive Ophthalmology and Biostatistics, Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyao","family":"Jian","sequence":"additional","affiliation":[{"name":"The Center for Health AI and Synthesis of Evidence, University of Pennsylvania, Philadelphia"},{"name":"The Graduate Group in Applied Mathematics and Computational Science, School of Arts and Sciences, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Asch","sequence":"additional","affiliation":[{"name":"Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Leonard Davis Institute of Health Economics, Philadelphia, Pennsylvania"},{"name":"Wharton School, University of Pennsylvania, Philadelphia"},{"name":"Division of General Internal Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia"},{"name":"The Center for Health AI and Synthesis of Evidence, University of Pennsylvania, Philadelphia"},{"name":"The Graduate Group in Applied Mathematics and Computational Science, School of Arts and Sciences, University of Pennsylvania, Philadelphia"},{"name":"Leonard Davis Institute of Health Economics, Philadelphia, Pennsylvania"},{"name":"Penn Medicine Center for Evidence-based Practice, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"issue":"11","key":"zld260230r1","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity.","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"issue":"11","key":"zld260230r3","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1056\/NEJMoa2500969","article-title":"Oral semaglutide at a dose of 25 mg in adults with overweight or obesity.","volume":"393","author":"Wharton","year":"2025","journal-title":"N Engl J Med"},{"issue":"17","key":"zld260230r4","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1161\/CIRCULATIONAHA.111.028381","article-title":"Food and Drug Administration\u2019s obesity drug guidance document: a short history.","volume":"125","author":"Colman","year":"2012","journal-title":"Circulation"},{"issue":"24","key":"zld260230r5","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1001\/jama.2025.4735","article-title":"Uptake of and disparities in semaglutide and tirzepatide prescribing for obesity in the US.","volume":"333","author":"Kim","year":"2025","journal-title":"JAMA"},{"key":"zld260230r7","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-026-02363-5","article-title":"Orforglipron: first approval.","author":"Shirley","year":"2026","journal-title":"Drugs"},{"issue":"6","key":"zld260230r8","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/jama.2026.0035","article-title":"What to know about the new semaglutide pill for obesity.","volume":"335","author":"Schweitzer","year":"2026","journal-title":"JAMA"},{"key":"zld260230r2","unstructured":"Novo Nordisk. Novo Nordisk A\/S: Wegovy\u00ae pill approved in the US as first oral GLP-1 for weight management. December 22, 2025. Accessed April 1, 2026. https:\/\/www.novonordisk.com\/content\/nncorp\/global\/en\/news-and-media\/news-and-ir-materials\/news-details.html?id=916472"},{"key":"zld260230r6","unstructured":"Truveta Research. Early uptake of Wegovy pill. February 11, 2026. Accessed April 2, 2026. https:\/\/www.truveta.com\/blog\/research\/featured-research\/oral-semaglutide-for-obesity-wegovy-pill\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2854937\/lei_2026_ld_260230_1790787584.5412.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:00:28Z","timestamp":1791385228000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2854937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":8,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.37779","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]}}}